A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity

Dong Hyun Kim, Zhen Xiao, Sanghoon Kwon, Xiaoxiao Sun, Daniel Ryerson, David Tkac, Ping Ma, Shwu Yuan Wu, Cheng Ming Chiang, Edward Zhou, H. Eric Xu, Jorma J. Palvimo, Lin Feng Chen, Byron Kemper, Jongsook Kim Kemper

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Acetylation of transcriptional regulators is normally dynamically regulated by nutrient status but is often persistently elevated in nutrient-excessive obesity conditions. We investigated the functional consequences of such aberrantly elevated acetylation of the nuclear receptor FXR as a model. Proteomic studies identified K217 as the FXR acetylation site in diet-induced obese mice. In vivo studies utilizing acetylation-mimic and acetylation-defective K217 mutants and gene expression profiling revealed that FXR acetylation increased proinflammatory gene expression, macrophage infiltration, and liver cytokine and triglyceride levels, impaired insulin signaling, and increased glucose intolerance. Mechanistically, acetylation of FXR blocked its interaction with the SUMO ligase PIASy and inhibited SUMO2 modification at K277, resulting in activation of inflammatory genes. SUMOylation of agonist-activated FXR increased its interaction with NF-κB but blocked that with RXRa, so that SUMO2-modified FXR was selectively recruited to and trans-repressed inflammatory genes without affecting FXR/RXRa target genes. A dysregulated acetyl/SUMO switch of FXR in obesity may serve as a general mechanism for diminished anti-inflammatory response of other transcriptional regulators and provide potential therapeutic and diagnostic targets for obesity-related metabolic disorders.

Original languageEnglish (US)
Pages (from-to)184-199
Number of pages16
JournalEMBO Journal
Volume34
Issue number2
DOIs
StatePublished - Jan 14 2015

Fingerprint

Acetylation
Obesity
Switches
Inflammation
Liver
Genes
Gene expression
Nutrients
Sumoylation
Food
Obese Mice
Glucose Intolerance
Macrophages
Gene Expression Profiling
Ligases
Cytoplasmic and Nuclear Receptors
Nutrition
Infiltration
Proteomics
Transcriptional Activation

Keywords

  • Acetylation
  • NF-κB
  • PIASy
  • Steatosis
  • SUMO2

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Kim, D. H., Xiao, Z., Kwon, S., Sun, X., Ryerson, D., Tkac, D., ... Kemper, J. K. (2015). A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. EMBO Journal, 34(2), 184-199. https://doi.org/10.15252/embj.201489527

A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. / Kim, Dong Hyun; Xiao, Zhen; Kwon, Sanghoon; Sun, Xiaoxiao; Ryerson, Daniel; Tkac, David; Ma, Ping; Wu, Shwu Yuan; Chiang, Cheng Ming; Zhou, Edward; Xu, H. Eric; Palvimo, Jorma J.; Chen, Lin Feng; Kemper, Byron; Kemper, Jongsook Kim.

In: EMBO Journal, Vol. 34, No. 2, 14.01.2015, p. 184-199.

Research output: Contribution to journalArticle

Kim, DH, Xiao, Z, Kwon, S, Sun, X, Ryerson, D, Tkac, D, Ma, P, Wu, SY, Chiang, CM, Zhou, E, Xu, HE, Palvimo, JJ, Chen, LF, Kemper, B & Kemper, JK 2015, 'A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity', EMBO Journal, vol. 34, no. 2, pp. 184-199. https://doi.org/10.15252/embj.201489527
Kim, Dong Hyun ; Xiao, Zhen ; Kwon, Sanghoon ; Sun, Xiaoxiao ; Ryerson, Daniel ; Tkac, David ; Ma, Ping ; Wu, Shwu Yuan ; Chiang, Cheng Ming ; Zhou, Edward ; Xu, H. Eric ; Palvimo, Jorma J. ; Chen, Lin Feng ; Kemper, Byron ; Kemper, Jongsook Kim. / A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. In: EMBO Journal. 2015 ; Vol. 34, No. 2. pp. 184-199.
@article{0fd30880d29f4f119092a6e112f57105,
title = "A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity",
abstract = "Acetylation of transcriptional regulators is normally dynamically regulated by nutrient status but is often persistently elevated in nutrient-excessive obesity conditions. We investigated the functional consequences of such aberrantly elevated acetylation of the nuclear receptor FXR as a model. Proteomic studies identified K217 as the FXR acetylation site in diet-induced obese mice. In vivo studies utilizing acetylation-mimic and acetylation-defective K217 mutants and gene expression profiling revealed that FXR acetylation increased proinflammatory gene expression, macrophage infiltration, and liver cytokine and triglyceride levels, impaired insulin signaling, and increased glucose intolerance. Mechanistically, acetylation of FXR blocked its interaction with the SUMO ligase PIASy and inhibited SUMO2 modification at K277, resulting in activation of inflammatory genes. SUMOylation of agonist-activated FXR increased its interaction with NF-κB but blocked that with RXRa, so that SUMO2-modified FXR was selectively recruited to and trans-repressed inflammatory genes without affecting FXR/RXRa target genes. A dysregulated acetyl/SUMO switch of FXR in obesity may serve as a general mechanism for diminished anti-inflammatory response of other transcriptional regulators and provide potential therapeutic and diagnostic targets for obesity-related metabolic disorders.",
keywords = "Acetylation, NF-κB, PIASy, Steatosis, SUMO2",
author = "Kim, {Dong Hyun} and Zhen Xiao and Sanghoon Kwon and Xiaoxiao Sun and Daniel Ryerson and David Tkac and Ping Ma and Wu, {Shwu Yuan} and Chiang, {Cheng Ming} and Edward Zhou and Xu, {H. Eric} and Palvimo, {Jorma J.} and Chen, {Lin Feng} and Byron Kemper and Kemper, {Jongsook Kim}",
year = "2015",
month = "1",
day = "14",
doi = "10.15252/embj.201489527",
language = "English (US)",
volume = "34",
pages = "184--199",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity

AU - Kim, Dong Hyun

AU - Xiao, Zhen

AU - Kwon, Sanghoon

AU - Sun, Xiaoxiao

AU - Ryerson, Daniel

AU - Tkac, David

AU - Ma, Ping

AU - Wu, Shwu Yuan

AU - Chiang, Cheng Ming

AU - Zhou, Edward

AU - Xu, H. Eric

AU - Palvimo, Jorma J.

AU - Chen, Lin Feng

AU - Kemper, Byron

AU - Kemper, Jongsook Kim

PY - 2015/1/14

Y1 - 2015/1/14

N2 - Acetylation of transcriptional regulators is normally dynamically regulated by nutrient status but is often persistently elevated in nutrient-excessive obesity conditions. We investigated the functional consequences of such aberrantly elevated acetylation of the nuclear receptor FXR as a model. Proteomic studies identified K217 as the FXR acetylation site in diet-induced obese mice. In vivo studies utilizing acetylation-mimic and acetylation-defective K217 mutants and gene expression profiling revealed that FXR acetylation increased proinflammatory gene expression, macrophage infiltration, and liver cytokine and triglyceride levels, impaired insulin signaling, and increased glucose intolerance. Mechanistically, acetylation of FXR blocked its interaction with the SUMO ligase PIASy and inhibited SUMO2 modification at K277, resulting in activation of inflammatory genes. SUMOylation of agonist-activated FXR increased its interaction with NF-κB but blocked that with RXRa, so that SUMO2-modified FXR was selectively recruited to and trans-repressed inflammatory genes without affecting FXR/RXRa target genes. A dysregulated acetyl/SUMO switch of FXR in obesity may serve as a general mechanism for diminished anti-inflammatory response of other transcriptional regulators and provide potential therapeutic and diagnostic targets for obesity-related metabolic disorders.

AB - Acetylation of transcriptional regulators is normally dynamically regulated by nutrient status but is often persistently elevated in nutrient-excessive obesity conditions. We investigated the functional consequences of such aberrantly elevated acetylation of the nuclear receptor FXR as a model. Proteomic studies identified K217 as the FXR acetylation site in diet-induced obese mice. In vivo studies utilizing acetylation-mimic and acetylation-defective K217 mutants and gene expression profiling revealed that FXR acetylation increased proinflammatory gene expression, macrophage infiltration, and liver cytokine and triglyceride levels, impaired insulin signaling, and increased glucose intolerance. Mechanistically, acetylation of FXR blocked its interaction with the SUMO ligase PIASy and inhibited SUMO2 modification at K277, resulting in activation of inflammatory genes. SUMOylation of agonist-activated FXR increased its interaction with NF-κB but blocked that with RXRa, so that SUMO2-modified FXR was selectively recruited to and trans-repressed inflammatory genes without affecting FXR/RXRa target genes. A dysregulated acetyl/SUMO switch of FXR in obesity may serve as a general mechanism for diminished anti-inflammatory response of other transcriptional regulators and provide potential therapeutic and diagnostic targets for obesity-related metabolic disorders.

KW - Acetylation

KW - NF-κB

KW - PIASy

KW - Steatosis

KW - SUMO2

UR - http://www.scopus.com/inward/record.url?scp=84921022704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921022704&partnerID=8YFLogxK

U2 - 10.15252/embj.201489527

DO - 10.15252/embj.201489527

M3 - Article

VL - 34

SP - 184

EP - 199

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 2

ER -